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Abstract
Background: Personal health records (PHRs) have the potential to improve patient self-management for chronic conditions
such as diabetes. However, evidence is mixed as to whether there is an association between PHR use and improved health
outcomes.
Objective: The aim of this study was to evaluate the association between sustained use of specific patient portal features
(Web-based prescription refill and secure messaging—SM) and physiological measures important for the management of type 2
diabetes.
Methods: Using a retrospective cohort design, including Veterans with diabetes registered for the My Health e Vet patient portal
who had not yet used the Web-based refill or SM features and who had at least one physiological measure (HbA1c, low-density
lipoprotein (LDL) cholesterol, blood pressure) in 2009-2010 (baseline) that was above guideline recommendations (N=111,686),
we assessed portal use between 2010 and 2014. We calculated the odds of achieving control of each measure by 2013 to 2014
(follow-up) by years of using each portal feature, adjusting for demographic and clinical characteristics associated with portal
use.
Results: By 2013 to 2014, 34.13% (38,113/111,686) of the cohort was using Web-based refills, and 15.75% (17,592/111,686)
of the cohort was using SM. Users were slightly younger (P<.001), less likely to be eligible for free care based on economic
means (P<.001), and more likely to be women (P<.001). In models adjusting for both features, patients with uncontrolled HbA1c
at baseline who used SM were significantly more likely than nonusers to achieve glycemic control by follow-up if they used SM
for 2 years (odds ratio—OR=1.24, CI: 1.14-1.34) or 3 or more years (OR=1.28, CI: 1.12-1.45). However, there was no significant
association between Web-based refill use and glycemic control. Those with uncontrolled blood pressure at baseline who used
Web-based refills were significantly more likely than nonusers to achieve control at follow-up with 2 (OR=1.07, CI: 1.01-1.13)
or 3 (OR=1.08, CI: 1.02-1.14) more years of Web-based refill use. Both features were significantly associated with improvements
in LDL cholesterol levels at follow-up.
Conclusions: Although rates of use of the refill function were higher within the population, sustained SM use had a greater
impact on HbA1c. Evaluations of patient portals should consider that individual components may have differential effects on
health improvements.
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Introduction
Diabetes affects over 29 million Americans [1] and was
estimated to have cost between $245 billion [2] and $322 billion
[3] in 2012. Despite advances in effective treatments [4], almost
half of those with type 2 diabetes do not meet recommended
targets for glycemic control, low-density lipoprotein (LDL)
cholesterol control, or blood pressure control [5]. Poor control
of diabetes is associated with poor health outcomes, increased
morbidity, and mortality [1,3]. Type 2 diabetes affects a large
portion of US Veterans, with 25% of Veterans having the
diagnosis [6,7].
Patients with diabetes and other chronic diseases do not do well
with episodic, transactional care limited to in-person visits. The
Institute of Medicine [8] has called for a shift toward continuous,
coordinated care, leveraging information technology to support
self-management and communication between clinic visits.
Type 2 diabetes requires patient self-management and effective
patient–provider communication to tailor treatments, manage
side effects, monitor physiological processes, and screen for
complications. Personal health records (PHRs) and patient
portals are technologies with the potential to increase patient
self-management and enable patients to better communicate
with their clinical teams [9,10].
Evidence for patient portal effectiveness for chronic disease
management is limited, and association with outcomes is mixed
[11]. Tenforde et al [12] found that portal use was associated
with improvements in diabetes-related quality measures but did
not find a dose-response association with varying intensity of
portal use and did not separate out effects by specific portal
feature. Potential benefits of portal use have included patient
reports of enhanced satisfaction, improved access outside of
face-to-face visits, and improved efficiency and quality of
face-to-face visits [13]. Studies from Kaiser [14] and Group
Health Cooperative [15,16] found significant associations
between use of secure messaging (SM) and improvements in
diabetes care, with significant performance improvements in
glycemic testing and control. Other studies have documented
improvements in medication adherence among diabetic patients
on statins exclusively using Web-based prescription refill
through a patient portal [17]. Association of portal use and
improvements in cholesterol and blood pressure effectiveness
of care measures [14] have also been documented among
patients with diabetes and hypertension.
Portals vary widely, adding to the difficulty in evaluating any
effects they may have on patients’ health outcomes. Some are
tethered to a health care system, others are not, some are disease
specific, whereas most are not [18,19]. The Department of
Veterans’ Affairs provides its patients with a portal, My
HealtheVet (MHV), including features allowing them to refill
VA prescriptions and send secure messages to their providers
[20-22]. These two features, SM and Web-based prescription
refill, are among the most common across portals and are the
most frequently used [23]. Veterans with diabetes have relatively
high adoption of MHV and of these key features [7].
This study examines whether diabetes outcomes are improved
for patients with type 2 diabetes who initiate use of key features
of the MHV patient portal compared with similar patients with
type 2 diabetes who are also registered for the portal but do not
initiate use of any of these features. To answer this question,
we focused on patients with a diagnosis of type 2 diabetes who
had at least one uncontrolled physiological measure (hemoglobin
A1c, LDL cholesterol, blood pressure) at baseline (2009-2010)
to examine whether those who had used the portal’s Web-based
prescription refill or SM features for the first time between 2010
and 2013 were more likely than nonusers to achieve control at
follow-up (2013-2014). We also sought to explore both the
separate and combined effects of Web-based refill and SM use
on physiological measures and whether sustained use was
associated with a greater probability of achieving control.
Methods
Study Design and Overview
We conducted a 5-year retrospective cohort study of Veterans
with type 2 diabetes registered for the MHV portal. Data for
these analyses came from the Veteran’s Health Administration’s
Corporate Data Warehouse, including administrative data,
clinical records for inpatient and outpatient care, and MHV
registration and use data. We used International Classification
of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)
diagnosis codes (October 1, 2007-March 31, 2009) to determine
type 2 diabetes diagnosis and determine patient characteristics
at baseline. Data from April 1, 2009 through March 31, 2014
were used to assess MHV use over time. Intermediate
physiological measures obtained during clinical care were
obtained at baseline and follow-up. In addition, we linked
income and educational attainment variables from the US Census
Bureau’s 2007- 2011 American Community Survey (5-year
estimates) to each Veteran via postal code.
Cohort Eligibility
We identified patients who had at least two outpatient records
or one inpatient record with an ICD-9-CM diagnosis code for
type 2 diabetes by March 2009 (N=1,207,703). Use of two or
more diabetes-related ICD-9-CM codes from inpatient or
outpatient visits has previously been determined to be the most
accurate way to identify patients with diabetes in VA
administrative data [24]. We then excluded patients who had
not used the VA for primary care in 2009 to 2010, who had
controlled or missing diabetes outcome measures, who were
not registered for the portal, or who had used the MHV
Web-based prescription refill or SM features before 2010 (see
Figure 1). We limited our analyses to those who were registered
to use the MHV portal to minimize differences in access to the
portal or in willingness to use the portal among users and
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nonusers so that we could focus on associations with actual use.
Our previous work has shown patients registered for the portal
(but not using features) to be a more appropriate and comparable
reference group [7]. Because our goal was to understand how
a patient portal could assist in achieving improvements in
physiological control, we also excluded those who were
controlled at baseline from the main analyses as those patients
had already successfully managed to control their physiological
measures without the use of MHV. The final analysis cohort
included 111,686 patients.
Figure 1. Cohort Selection.
Variables
Dependent Variables—Diabetes-Related Physiological
Measures: HbA1c, LDL, Systolic and Diastolic Blood
Pressures
We used the American Diabetes Association’s guidelines to
define cutoffs for glycemic, cholesterol, and blood pressure
control [25]. We defined uncontrolled blood glucose at baseline
(April 2009-March 2010) if the patient’s average hemoglobin
A1c (HbA1c) during that period was greater than or equal to
7.0% (53 mmol/mol) and uncontrolled LDL cholesterol at
baseline if the patient’s average cholesterol reading during that
same period was greater than or equal to 100 mg/dL (2.586
mmol/L). Similarly, we determined that a patient had
uncontrolled blood pressure if the average systolic blood
pressure at baseline (assessed by averaging all readings during
the baseline year) was 140 mmHg or higher, or the average
diastolic blood pressure (similarly averaged across the baseline
year) was 80 mmHg or higher. To achieve control by follow-up,
patients had to lower their readings to below the cutoffs (blood
glucose and LDL cholesterol) or achieve control over both
systolic and diastolic blood pressures (blood pressure). A binary
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indicator for whether a patient with uncontrolled values at
baseline achieved control by follow-up (2013-2014) was the
dependent variable for the logistic regression models.
Independent Variables—Use of the Portal: Registration,
Use of Web-Based Prescription Refill and Secure
Messaging
Among Veterans registered by April 1, 2013, we measured use
of two key features of the portal, which had been available
throughout the study period: the Web-based prescription refill
feature and the SM feature and used a binary indicator of any
use to describe the samples. We assessed how often each patient
used each feature during the potential exposure period (April
2010-March 2013). At some facilities, patients were prompted
to try these features (eg, send a test message to one’s primary
care team) as part of a MHV training. We therefore defined
“use” as two or more prescriptions filled online via the MHV
portal per year or two or more SMs sent per year, to ensure we
captured actual use and not just attendance at a training session.
To measure dose of exposure, our primary measure of use for
each portal feature was a categorical variable indicating whether
a patient had used each feature two or more times per year over
1 year, 2 years, or for 3 or more years during the potential
exposure period. A continuous variable measuring years of use
(ie, years with 2+ refills or 2+ SMs sent) for each portal feature
was used for tests for trend.
Other Covariates
Other covariates we used included demographic characteristics
such as patient age, gender, race or ethnicity, urban, suburban,
or rural residence, educational attainment, and income. In
multivariable models, we adjusted for age, gender, race,
comorbidities, and available measures of socioeconomic status
because these have been significantly associated with adoption
of SM and patient portals in previous studies [9,26]. For income,
we included a measure of whether the patient was eligible for
free care from the Veterans Health Administration based on
low income. Because data on Veterans’ income and educational
attainment do not exist in the VA Corporate Data Warehouse,
we also linked Census data by postal code of residence on the
percentage of adults aged older than 25 years who have attained
a bachelor’s degree or higher and the median per capita earnings
in the past 12 months (in 2011 inflation-adjusted dollars) among
those aged 25 years and older with earnings. We also adjusted
for the number of primary care visits a patient had during the
baseline year and the number of comorbidities they had as
determined by the Elixhauser algorithm for identifying
comorbidities from administrative data [27].
Analyses
We characterized the overall cohort and examined means and
distributions of patient demographic and clinical characteristics
by use, both overall and for those with specific uncontrolled
physiological measures at baseline. We calculated the proportion
of patients with diabetes in our cohort using each feature over
each year of the study and the average number of prescriptions
refilled or secure messages sent during each year. Our primary
goal was to assess the association of use of patient portal features
with change in diabetes-relevant physiological measures
(HbA1c, LDL, BP). To achieve this goal, we first calculated
means and binomial confidence intervals (CIs) for the proportion
of patients who were uncontrolled at baseline who achieved
control at follow-up, stratified by the number of years of use of
the SM or Web-based refill features. We then constructed a
series of logistic regression models predicting control of each
physiological measure at follow-up based on categorical
measures of portal use (years of use of each feature), adjusting
for the covariates described previously. All logistic regression
models were adjusted for patient age; gender; race or ethnicity;
eligibility for free VA health care; number of Elixhauser
comorbidities at baseline; number of primary care visits at
baseline (in 2009-2010) and during the study period
(2010-2014); urban, suburban, rural, or highly rural residence;
median income by postal code; and the percentage of college
graduates in the patient’s residential postal code. In addition,
models for control of blood pressure, cholesterol, and HbA1c
at follow-up (2013-2014) were adjusted for the patient’s mean
baseline blood pressure, LDL cholesterol, or HbA1c value in
2009 to 2010, respectively. Separate models were first run for
each feature (Web-based prescription refill use and SM use)
because there was a moderate correlation between uses of the
two features. To further evaluate the independent effect of each
feature, we also ran combined logistic models, which included
both Web-based prescription refill use and SM use in the same
models. To test for dose response, we then ran tests of trend
treating the number of years of use of each feature as a
continuous variable. We also conducted sensitivity analyses to
see whether results changed depending on (1) our definition of
use (ie, defining use as one or more uses of a feature in a given
year) or (2) inclusion of patients who met other inclusion criteria
but were controlled at baseline in the analysis sample.
Results
Feature Use
Within our cohort of 111,686 patients (see Figure 1), 50,482
(45.20%) used Web-based prescription refills or SM or both at
least twice per year between April 2010 and March 2014, and
61,204 (54.80%) used neither.
Patient Characteristics
Table 1 describes the characteristics of the overall sample and
examines differences between patients who used the Web-based
prescription refill feature or the SM feature or both in MHV
between April 2010 and March 2014 and those who did not.
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Table 1. Characteristics of patients with type 2 diabetes registered for My HealtheVet, overall and by use or nonuse of the Web-based refill or secure
messaging features as of March 2014.
Difference between user and nonuser
groups (Pearson’s chi-square or 2-sided
t-test)
Used Web-based
refill or SM or
both as of March
2014 (users)
Used neither
Web-based refill
nor SM as of
March 2014
(nonusers)
OverallVariables
50,48261,204111,686N
t111684 = 45.2, P<.00160.63 (9.5)63.22 (9.6)62.05 (9.6)Age (mean (SD)
χ21 = 67.2, P<.0014.08%3.16%3.58%Gender (% female)
Race or ethnicity
Reference group for χ270.84%67.25%68.87%White
χ21 = 280.3, P<.00114.90%18.64%16.95%African-American
χ21= 1.1, P=.2945.76%5.63%5.69%Latino
χ21 = 0.1, P=.7551.12%1.08%1.10%
Native Hawaiian or
Pacific Islander
χ21 = 5.9, P=.0150.90%0.73%0.81%Asian
χ21 = 1.8, P=.1780.70%0.73%0.71%
American Indian or
Alaska Native
χ21 = 9.1, P=.0035.79%5.94%5.87%
Unknown to patient,
refused, or missing
χ21 = 137.6, P<.00118.87%21.71%20.43%
Percent eligible for free VA health care based
on income
t108985 = −0.6596, P=.509533,568.51
(8,842.24)
33,532.67
(8,996.24)
33,548.86
(8,926.98)
Median income in postal code of residence
US$ (mean (SD))
t109086= −1.9398, P=.052423.54%
(12.7)
23.39% (12.8)23.46% (12.7 )Percent of adults with a university degree or
higher in postal code of residence (mean (SD))
Location
Reference group for χ273.19%73.27%73.23%Urban (%)
χ21 = 0.3, P=.59713.32%13.46%13.40%Suburban (%)
χ21 = 1.3, P=.2597.12%7.32%7.23%Rural (%)
χ21 = 7.5, P=.0066.38%5.95%6.14%Highly rural (%)
t111357=−1.826, P=.06795.59 (2.5)5.56 (2.6)5.57 (2.5)Number of Elixhauser comorbidities at base-
line (mean (SD))
t111684 = −3.0046, P=.00274.43 (3.6)4.37 (3.6)4.40 (3.6)Number of primary care visits at baseline
(mean(SD))
t111684 = −17.86, P<.00118.34 (13.0)16.97 (12.6)17.59
(12.8)
Number of primary care visits from 2010 to
2014 (mean (SD))
Compared with patients who did not use either of the features,
patients who used Web-based refill or SM were slightly younger
(60.6 years vs 63.2 years, P<.001), more likely to be female
(4.08% vs 3.16%, P<.001), and less likely to be eligible for free
VA care based on low economic means (18.87% vs 21.71%,
P<.001). There were significant differences in race or ethnicity
between users and nonusers, with African-American (P<.001),
Asian (P=.015), and patients of unknown race (P=.003) less
likely than white patients to be users. The difference was most
marked between African-American and white patients (39.73%
(7,521/18,931) of African-American patients were users vs
46.49% (35,759/76,920) of white patients, P<.001). Although
most patients resided in urban areas, urban patients were slightly
less likely to be users than patients residing in areas designated
as highly rural (45.06% (36,078/80,060) vs 46.80%
(3,143/6,716), P=.006).
There were no significant differences in the number of
Elixhauser comorbidities at baseline (P=.0679), median income
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by postal code of residence (P=.5095), percentage of adults with
a bachelor’s degree or higher in postal code of residence
(P=.0524). There was a statistically significant difference in the
number of primary care visits at baseline in the overall cohort
(4.37 visits for nonusers vs 4.43 visits for users at baseline,
P=.0027), but this difference vanished when looking at analysis
subgroups based on uncontrolled measure at baseline (see Table
2). There was a highly significant difference in the number of
primary care visits between 2010 and 2014 (16.97 for nonusers
vs 18.34 visits for users, P<.001). Users also showed evidence
of higher primary care utilization in all analysis subgroups (see
Table 2).
Further detail describing the characteristics based on each
uncontrolled measure (ie, the sample for each logistic regression
model) is summarized in Table 2.
Table 2. Demographics of patients with type 2 diabetes registered for My HealtheVet by uncontrolled physiological measure at baseline and by use of
the portal.
Uncontrolled MeasureVariables
Blood Pressure
BP≥140/80 mmHg
Low-density Lipoprotein
LDL≥100mg/dL
Hemoglobin A1c
A1c ≥7.0%
Used SM or Web-based
refill
Registered, no
use
Used SM or
Web-based re-
fill
Registered, no
use
Used SM or
Web-based re-
fill
Registered, no
use
26,47131,90716,15318,89830,91736,305N
60.13 (9.7)62.63 (9.7)58.68 (9.6)61.47 (9.6)60.28 (9.2)62.66 (9.2)Age (mean (SD)
3.58%2.88%6.53%4.87%3.71%2.86%Gender (% female)
Race or ethnicity
68.44%64.55%67.62%64.21%70.98%66.88%White
17.25%21.38%17.56%22.14%14.84%19.12%African-American
5.63%5.53%6.27%5.79%6.03%6.08%Latino
1.21%1.08%1.08%1.04%1.11%1.08%Native Hawaiian Pacific Is-
lander
0.87%0.72%1.00%0.71%0.89%0.75%Asian
0.70%0.71%0.84%0.69%0.70%0.73%American Indian or Alaska Na-
tive
5.91%6.02%5.64%5.42%5.45%5.36%Unknown to patient, refused,
or missing
18.96%21.93%18.76%21.61%19.40%22.38%Percent eligible for free VA health
care
33,424.07
(8763.60)
33,364.98
(8815.67)
33,197.85
(8674.04)
33,111.41
(8813.43)
33,548.58
(8839.33)
33,453.54
(8925.47)
Median income in postal code US$
(mean (SD))
23.46% (12.6)23.27% (12.7)23.20% (12.4)22.95% (12.6)23.32% (12.6)23.12% (12.7)Percent adults with a university
degree or higher in postal code
(mean(SD))
Location
72.91%73.40%73.43%73.32%73.12%73.21%Urban (%)
13.47%13.54%13.15%13.64%13.15%13.34%Suburban (%)
7.12%7.14%7.05%7.18%7.24%7.41%Rural (%)
6.50%5.93%6.37%5.86%6.50%6.04%Highly rural (%)
5.51 (2.4)5.54 (2.5)5.45 (2.4)5.40 (2.5)5.72 (2.5)5.70 (2.6)Number Elixhauser comorbidities
at baseline (mean (SD))
4.30 (3.4)4.29 (3.5)4.38 (3.5)4.32 (3.5)4.66 (3.7)4.64 (3.8)Number of primary care visits at
baseline (2009-10; mean(SD))
18.17 (12.5)16.97 (12.5)18.29 (12.7)17.09 (12.4)19.17 (13.3)18.04 (12.9)Number of primary care visits;
2010 to 2014, mean (SD)
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Portal Use
Use of Web-based refills and SM increased steadily from 2010
to 2014 (Figure 2). Among registered patients with diabetes
who had not used the portal before 2010, only 7.98%
(8,917/111,686) used Web-based prescription refills in 2010 to
2011, and the average number of refills per year was 3.13 per
user. In the same year, as SM was just being implemented at
most facilities, only 0.22% (241/111,686) used SM and sent an
average of 0.059 messages per user. By 2013 to 2014, the
numbers had risen to 34.13% (38,113/111,686) of new users
using Web-based refills, filling an average of 27.84 prescriptions
each, and 15.75% (17,592/111,686) were using SM, sending
an average of 9.46 messages each.
Figure 2. Proportion of patients with type 2 diabetes registered for My HealtheVet and first using Web-based prescription refills or secure messaging
after 2010, increase in feature adoption over time, and average number of uses per user per year.
Association of Patient Portal Use and Change in
Diabetes Physiological Measures over 5 Years
The logistic regression results are presented in Table 3.
Our single-feature logistic regression models (Models 1a-c and
Models 2a-c) showed that patients with uncontrolled HbA1c at
baseline (2009-2010) were significantly more likely to achieve
glycemic control at follow-up (2013-2014) if they used SM for
2 or more years. The odds of having an HbA1c below 7.0% (53
mmol/mol) at follow-up were 22% higher (after 2 years of use,
odds ratio: OR=1.22, CI: 1.13-1.32) and 28% higher (after 3 or
more years, OR=1.28, CI: 1.13-1.44), for those using SM
compared with those who never used it.
However, use of Web-based prescription refills was only
associated with glycemic control at follow-up after 3 or more
years of use (OR=1.07, CI: 1.01-1.14). Those with uncontrolled
blood pressure at baseline were significantly more likely to
achieve control at follow-up only with 2 (OR=1.06, CI:
1.01-1.12) or 3 or more (OR=1.05, CI: 1.00-1.11) years of
Web-based refill use, compared with nonusers. Use of SM was
not significantly associated with improvements in blood pressure
control. Both Web-based refill use and SM use were
significantly associated with improvements in LDL cholesterol
levels at follow-up. Compared with nonusers, the odds of users
having LDL cholesterol below 100 mg/dL (2.586 mmol/L) were
12% higher with 2 years of Web-based refill use (OR=1.12, CI:
1.05-1.20), 16% higher with 3+ years of Web-based refill Use
(OR=1.16, CI: 1.08-1.24), 9% higher with 1 year of SM use
(OR=1.09, CI: 1.01-1.18), 17% higher with 2 years of SM use
(OR=1.17, CI: 1.07-1.27), and 22% higher with 3+ years of SM
use (OR=1.22, CI: 1.06-1.40).
We also ran logistic regression models identical to those
mentioned previously that included both years of SM and
Web-based refill use in the same model (Models 3a-c), as well
as logistic regression models that included years of SM or
Web-based refill use as a continuous variable as a test for trend
(Models 4a-c). The conclusions remained largely unchanged,
although ORs for the association between SM use and LDL
were more attenuated (and no longer significant with the
exception of 2 years of SM use) in the combined model. The
combined model (and test for trend) did not show a significant
association between SM use and blood pressure control (P=.370
for trend), or between Web-based refill use and glycemic control
(P=.585 for trend); however, tests for trend revealed significant
dose-response relationships between use of SM and glycemic
control (P<.001), use of Web-based refill and blood pressure
control (P=.001), and use of both features and LDL control
(P<.001 and P=.015 for trend, respectively, for refills and SM
use).
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Table 3. Adjusted odds of being in control at follow-up (OR (95% CI)) for a patient with uncontrolled physiological measures (HbA1c, LDL, or blood
pressure) at baseline, based on years of portal feature use.
Health Outcomes in 2013-14Modelsa
Blood Pressure
SBP<140 mmHg
DBP<80 mmHg
Low-density Lipoprotein
LDL < 100 mg/dL
(2.586 mmol/l)
Hemoglobin A1c
HbA1c<7%
(53 mmol/mol)
Models 1a-c: adjusted odds ratios (95% CI) for being controlled in 2013-2014 among patients with uncontrolled physiological measures in
2009-10 based on years of Web-based prescription refill usea
Web-based prescription refill use
ReferenceReferenceReferenceNone
1.02 (0.97, 1.08)1.01 (0.95, 1.08)0.99 (0.93, 1.05)1 year
1.06 (1.01, 1.12)b1.12 (1.05, 1.20)c1.01 (0.95, 1.08)2 years
1.05 (1.00, 1.11)b1.16 (1.08, 1.24)d1.07 (1.01, 1.14)b3 or more years
Models 2a-c: adjusted odds ratios (95% CI) for being controlled in 2013-2014 among patients with uncontrolled physiological measures in
2009-2010 based on years of secure messaging usea
Secure messaging use
ReferenceReferenceReferenceNone
1.03 (0.97, 1.09)1.09 (1.01, 1.18)b1.03 (0.96, 1.10)1 year
1.03 (0.96, 1.10)1.17 (1.07, 1.27)c1.22 (1.13, 1.32)d2 years
1.00 (0.90, 1.12)1.22 (1.06, 1.40)c1.28 (1.13, 1.44)d3 or more years
Models 3a-c: adjusted odds ratios (95% CI) for being controlled in 2013-2014 among patients with uncontrolled physiological measures in
2009-2010 based on years of both featuresa
Web-based prescription refill use
ReferenceReferenceReferenceNone
1.02 (0.97, 1.07)1.01 (0.94, 1.08)0.96 (0.91, 1.03)1 year
1.07 (1.01, 1.13)b1.13 (1.05, 1.21)c0.96 (0.90, 1.03)2 years
1.08 (1.02, 1.14)c1.13 (1.05, 1.22)c1.00 (0.94, 1.07)3 or more years
Secure messaging use
ReferenceReferenceReferenceNone
1.00 (0.94, 1.07)1.05 (0.97, 1.14)1.04 (0.97, 1.12)1 year
0.98 (0.91, 1.05)1.10 (1.00, 1.21)b1.24 (1.14, 1.34)d2 years
0.95 (0.85, 1.07)1.12 (0.96, 1.30)1.28 (1.12, 1.45)d3 or more years
Models 4a-c: combined tests for trend predicting controlled outcomes in 2013-2014 among patients with uncontrolled physiological measures
in 2009-2010 based on years of use for both featuresa
P=.001P<.001P=.585Web-based prescription refill use
P=.370P=.015P<.001Secure messaging use
aAll models adjust for patient characteristics in Table 1 including age, gender, race or ethnicity, eligibility for free care, geographic location, number
of Elixhauser comorbidities, and baseline number of primary care visits in 2009 to 2010. In addition, models adjusted for the patient’s physiological
measure (blood pressure, LDL cholesterol, or HbA1c value) in 2009 to 2010, median income in the patient’s residential zip code, and the percentage
of college graduates in the patient’s residential postal code.
bOdds ratios are significant at the P<.05 level as indicated.
cOdds ratios are significant at the P<.01 level as indicated.
dOdds ratios are significant at the P<.001 level as indicated.
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Figure 3. Proportion controlled at follow-up, out of all diabetics uncontrolled for that specific measure at baseline (proportion and binomial CIs).
Figure 3 shows the predicted probability of achieving control
over each measure by follow-up based on years of refill and
SM use among those uncontrolled at baseline for each measure.
The figure illustrates how sustained use of each tool is associated
with improvements in control of physiological measures.
Sensitivity Analyses
We conducted sensitivity analyses to see whether our results
would change with the inclusion of those whose physiological
measures were controlled at baseline, but otherwise met criteria
for inclusion. Although the ORs were attenuated, significant
tests for trend revealed the same relationships between feature
use and being in control at follow-up for all the measures.
Similarly, when use was defined as use of a feature even once
in a given year, ORs were again somewhat attenuated; however,
the results, including the tests for trend, led to identical
conclusions about the associations between feature use and
controlled physiological outcomes at follow-up.
Discussion
Principal Findings
Within this cohort of patients with type 2 diabetes and
uncontrolled physiological measures, we saw increasing activity
on the MHV patient portal between 2010 and 2014. The rate of
use and increase in use was greater for Web-based refills than
for SM. We observed small, statistically significant, and
potentially meaningful improvement in physiological measures
among diabetic patients who initiated and sustained use of
Web-based refills or SM or both via MHV. However, the
association varied by specific MHV feature. Where a significant
association was found, use of SM was associated with higher
odds of improved outcomes than use of Web-based refills.
Comparison With Prior Work
The association between use of SM and improved diabetes
physiological measures is consistent with that of prior research
[14-16]; however, we were able to add information on the effects
of sustained use over many years. For most measures, we found
a dose-response effect on outcomes, suggesting that sustained
use of the feature was associated with greater likelihood of being
controlled at follow-up. The more years the patient used the
feature, the greater the odds of achieving control compared with
those who did not use the feature. Use of SM was associated
with improvements in glycemic control with sustained use over
2 to 3+ years. Type 2 diabetic patients with uncontrolled blood
pressure were more likely to achieve blood pressure control
with 2 to 3+ years’ use of Web-based medication refills through
MHV. Both prescription refills and SM were associated with
improvements in lipid levels with sustained use. Adjusting for
use of both the features in the model did shift the magnitude of
the odds of achieving control. This suggests that the association
between patient portal use and health outcomes will vary based
on the combination of different features used and how patients
are using each feature for self-management of their health
conditions.
One mechanism by which Web-based medication refills may
affect health outcomes may be through improved adherence to
prescribed medications. In prior work, MHV use has been
associated with improvements in antiretroviral adherence [28].
To the extent that Web-based refills increase the likelihood of
refilling prescriptions, they may improve availability of
medications, which may lead to improvements in adherence. If
the Web-based refill feature improves adherence to
antihypertensives and statins, they are likely to improve
hypertension and lipid control over time. However, we did not
see an association between sustained use of Web-based refills
and improvements in HbA1c levels. Because HbA1c is a
measure of blood sugar levels over several months, it may take
a longer time for improved adherence to diabetes medications
to result in measurable improvements, unlike blood pressure
and LDL cholesterol, which can result in more rapid
improvements even with improved short-term adherence to
antihypertensives and statins. A patient’s blood sugar levels are
also more sensitive to patient diet and self-management, as well
as adequate medication titration, both of which may require
more patient–provider communication and clinician support to
achieve.
SM has been shown to improve patient ratings of
patient–provider communication [29]. Thus, SM may also affect
adherence by facilitating patient–provider communication about
medication or behavioral concerns, which are barriers to
adherence. It may also facilitate coordination of care and make
it easier for primary care clinicians to refer patients to other
related services such as nutrition consults, diabetes counseling,
or weight loss programs [30]. This may explain why glycemic
control, which requires significant and often complex patient
self-management in addition to medication management, was
found to be significantly associated with sustained use of SM.
This work also expands on previous research that has often
focused generally on the patient portal or PHR use [12] or the
use of a particular feature such as SM [9,14,17], without
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accounting for their relative effects when used in combination
with other features. As features continue to be added to portals,
further research should continue to examine the effects of
different portal features both separately and in combination, to
determine which features are most effective at improving the
specific patient outcomes of interest.
Patients who used one or both features during the study period
were more likely to be younger, female, white, and were less
likely to be socioeconomically disadvantaged than other patients
with diabetes who met our inclusion criteria. Numerous studies
have documented sociodemographic differences in patient portal
access and adoption [26,31-33]. Although we attempted to
minimize differences in access by limiting our analyses to
patients who had registered for the portal, we still observed
differences across groups. It is important to ensure that any
improvements in health status achieved through the patient
portal do not further widen existing disparities in health because
of disparities in portal access or adoption. Lyles et al found that
racial or ethnic difference in diabetic patients’ shared medical
record use was not fully explained by differences in patient
sociodemographics, patient health status, or provider
encouragement of SM [26]. We will have to be mindful of these
potential disparities and specifically target vulnerable patients
with support interventions for use of portal features found to
significantly affect health outcomes.
Limitations
There are a number of limitations to this study. The VA patient
portal has been deployed nationwide. As all patients are free to
choose whether to use the patient portal, it is difficult to limit
access or to randomize access to various features to conduct a
randomized controlled trial. Because this is an observational
study, it is impossible to ensure that the comparison group (ie,
the nonusers) is similar in all ways to the portal users. As
discussed, we limited the sample to those who had registered
to use the portal to reduce heterogeneity in measured and
unmeasured confounders. In our prior research [7], we have
demonstrated that demographic characteristics were more similar
when comparing registered users and nonusers, versus
comparing those registered and those not registered. By using
patients with diabetes who had registered for MHV (but not
used the prescription refill or SM features more than once, if
ever,) as a comparison group, we minimized some of this bias
by limiting our analyses to patients who had access to the portal
and who had attended a training or otherwise shown an interest
in using it at some point. We saw that the patients in the
comparison group for each logistic regression model were very
similar in terms of their baseline health care utilization (number
of primary care visits) and number of Elixhauser comorbidities
(see Table 2). However, without a measure of patient
engagement, there is still the possibility that patients may
self-select to use these features precisely because they are
already more engaged in their care; the lack of a measure of
patient engagement is another limitation of this study.
Randomized encouragement trials [34] may be one method to
strengthen the rigor of future work.
Conclusions
Recognizing that our study is an observational study and that
the associations cannot be considered causal, the availability of
multiple years of observational data, detection of a dose
response, and adjustment for patient characteristics known to
influence technology use and diabetes outcomes strengthen the
potential conclusions we can draw from this analysis about the
differential effects use of patient portal features may have on
physiological outcomes. The results in this study suggest that
measuring the relative use and relative association of each
feature of a patient portal is critical because each can have a
different effect on changes in health care and health outcomes.
Future research should also focus on uncovering the mechanisms
(causal pathways) through which portal use leads to
physiological improvements. Does improved communication
with providers via SM lead to greater patient engagement
between visits, sustained behavior changes, better continuity of
care, improved medication titration by the clinical team, or
improved adherence to medications by the patients? What
portion of the engagement might be explained by other portal
features such as the ability to track and chart their blood glucose
or blood pressure measurements? A study of adult diabetes
patients at Kaiser Permanente found that both patient
nonadherence to medications for glycemic, lipid, or blood
pressure control and lack of provider treatment intensification
occurred frequently among patients whose outcomes are above
desired target levels [35]. It may be that portal use assists with
patient adherence to medications by facilitating prescription
refills, and that patient–provider communication between
face-to-face visits can lead to improvements in levels of
appropriate treatment intensification by providers. These
pathways must be better understood to leverage portal features
for interventions.
 
Acknowledgments
Dr. Shimada was supported by a Career Development Award (CDA 10-210) from the Department of Veterans Affairs Health
Services Research and Development Service and the VA eHealth QUERI (EHQ 10-190). The contents do not represent the views
of the US Department of Veterans Affairs or the US Government.
Conflicts of Interest
None declared.
References
J Med Internet Res 2016 | vol. 18 | iss. 7 | e179 | p.10http://www.jmir.org/2016/7/e179/
(page number not for citation purposes)
Shimada et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
1. Centers for Disease Control Prevention. Estimates of Diabetes and Its Burden in the United States, 2014. In: National
Diabetes Statistics Report. Atlanta, GA: U.S. Department of Health and Human Services; 2014.
2. American DA. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013 Apr;36(4):1033-1046. [doi:
10.2337/dc12-2625] [Medline: 23468086]
3. Dall TM, Yang W, Halder P, Pang B, Massoudi M, Wintfeld N, et al. The economic burden of elevated blood glucose levels
in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes. Diabetes Care 2014
Dec;37(12):3172-3179. [doi: 10.2337/dc14-1036] [Medline: 25414388]
4. Nathan DM. Diabetes: Advances in diagnosis and treatment. JAMA 2015 Sep 8;314(10):1052-1062. [doi:
10.1001/jama.2015.9536] [Medline: 26348754]
5. Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care,
1999-2010. N Engl J Med 2013 Apr 25;368(17):1613-1624. [doi: 10.1056/NEJMsa1213829] [Medline: 23614587]
6. Gervera K, Graves BA. Integrating Diabetes Guidelines into a Telehealth Screening Tool. Perspect Health Inf Manag
2015;12:1f [FREE Full text] [Medline: 26396557]
7. Shimada SL, Brandt CA, Feng H, McInnes DK, Rao S, Rothendler JA, et al. Personal health record reach in the Veterans
Health Administration: a cross-sectional analysis. J Med Internet Res 2014;16(12):e272 [FREE Full text] [doi:
10.2196/jmir.3751] [Medline: 25498515]
8. Institute of Medicine Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system
for the 21st century. Washington, DC: National Academy Press; 2001.
9. Weppner WG, Ralston JD, Koepsell TD, Grothaus LC, Reid RJ, Jordan L, et al. Use of a shared medical record with secure
messaging by older patients with diabetes. Diabetes Care 2010 Nov;33(11):2314-2319 [FREE Full text] [doi:
10.2337/dc10-1124] [Medline: 20739686]
10. Ricciardi L, Mostashari F, Murphy J, Daniel JG, Siminerio EP. A national action plan to support consumer engagement
via e-health. Health Aff (Millwood) 2013 Feb;32(2):376-384 [FREE Full text] [doi: 10.1377/hlthaff.2012.1216] [Medline:
23381531]
11. Tenforde M, Jain A, Hickner J. The value of personal health records for chronic disease management: what do we know?
Fam Med 2011 May;43(5):351-354 [FREE Full text] [Medline: 21557106]
12. Tenforde M, Nowacki A, Jain A, Hickner J. The association between personal health record use and diabetes quality
measures. J Gen Intern Med 2012 Apr;27(4):420-424 [FREE Full text] [doi: 10.1007/s11606-011-1889-0] [Medline:
22005937]
13. Wade-Vuturo A, Mayberry LS, Osborn CY. Secure messaging and diabetes management: experiences and perspectives of
patient portal users. J Am Med Inform Assoc 2013 May 1;20(3):519-525 [FREE Full text] [doi: 10.1136/amiajnl-2012-001253]
[Medline: 23242764]
14. Zhou YY, Kanter MH, Wang JJ, Garrido T. Improved quality at Kaiser Permanente through e-mail between physicians
and patients. Health Aff (Millwood) 2010 Jul;29(7):1370-1375 [FREE Full text] [doi: 10.1377/hlthaff.2010.0048] [Medline:
20606190]
15. Harris L, Haneuse SJ, Martin DP, Ralston JD. Diabetes quality of care and outpatient utilization associated with electronic
patient-provider messaging: a cross-sectional analysis. Diabetes Care 2009 Jul;32(7):1182-1187 [FREE Full text] [doi:
10.2337/dc08-1771] [Medline: 19366959]
16. Harris L, Koepsell TD, Haneuse SJ, Martin DP, Ralston JD. Glycemic control associated with secure patient-provider
messaging within a shared electronic medical record: a longitudinal analysis. Diabetes Care 2013 Sep;36(9):2726-2733
[FREE Full text] [doi: 10.2337/dc12-2003] [Medline: 23628618]
17. Sarkar U, Lyles CR, Parker MM, Allen J, Nguyen R, Moffet HH, et al. Use of the refill function through an online patient
portal is associated with improved adherence to statins in an integrated health system. Med Care 2014 Mar;52(3):194-201
[FREE Full text] [doi: 10.1097/MLR.0000000000000069] [Medline: 24374412]
18. Kaelber D, Pan EC. The value of personal health record (PHR) systems. AMIA Annual Symposium Proceedings 2008;Nov
6:343-347. [Medline: 18999276]
19. Detmer D, Bloomrosen M, Raymond B, Tang P. Integrated personal health records: transformative tools for consumer-centric
care. BMC Med Inform Decis Mak 2008;8:45 [FREE Full text] [doi: 10.1186/1472-6947-8-45] [Medline: 18837999]
20. Nazi K, Woods SS. MyHealtheVet PHR: a description of users and patient portal use. AMIA Annu Symp Proc 2008;Nov
6:1182. [Medline: 18999142]
21. Chumbler NR, Haggstrom D, Saleem JJ. Implementation of health information technology in Veterans Health Administration
to support transformational change: telehealth and personal health records. Med Care 2011 Dec;49 Suppl:S36-S42. [doi:
10.1097/MLR.0b013e3181d558f9] [Medline: 20421829]
22. Nazi KM, Hogan TP, Wagner TH, McInnes DK, Smith BM, Haggstrom D, et al. Embracing a health services research
perspective on personal health records: lessons learned from the VA My HealtheVet system. J Gen Intern Med 2010 Jan;25
Suppl 1:62-67 [FREE Full text] [doi: 10.1007/s11606-009-1114-6] [Medline: 20077154]
23. Nazi KM. Veterans' voices: use of the American Customer Satisfaction Index (ACSI) Survey to identify My HealtheVet
personal health record users' characteristics, needs, and preferences. J Am Med Inform Assoc 2010;17(2):203-211 [FREE
Full text] [doi: 10.1136/jamia.2009.000240] [Medline: 20190065]
J Med Internet Res 2016 | vol. 18 | iss. 7 | e179 | p.11http://www.jmir.org/2016/7/e179/
(page number not for citation purposes)
Shimada et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
24. Miller DR, Safford MM, Pogach LM. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans
Affairs based on computerized patient data. Diabetes Care 2004 May;27 Suppl 2:B10-B21. [Medline: 15113777]
25. American Diabetes Association. Standards of Medical Care in Diabetes—2013. Diabetes Care 2013;36(Suppl 1):S11-S66
[FREE Full text] [doi: 10.2337/dc13-S011]
26. Lyles CR, Harris LT, Jordan L, Grothaus L, Wehnes L, Reid RJ, et al. Patient race/ethnicity and shared medical record use
among diabetes patients. Med Care 2012 May;50(5):434-440. [doi: 10.1097/MLR.0b013e318249d81b] [Medline: 22354209]
27. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J, et al. Coding algorithms for defining comorbidities in
ICD-9-CM and ICD-10 administrative data. Med Care 2005 Nov;43(11):1130-1139. [Medline: 16224307]
28. McInnes DK, Shimada SL, Rao SR, Quill A, Duggal M, Gifford AL, et al. Personal health record use and its association
with antiretroviral adherence: survey and medical record data from 1871 US veterans infected with HIV. AIDS Behav 2013
Nov;17(9):3091-3100. [doi: 10.1007/s10461-012-0399-3] [Medline: 23334359]
29. Lin C, Wittevrongel L, Moore L, Beaty BL, Ross SE. An Internet-based patient-provider communication system: randomized
controlled trial. J Med Internet Res 2005;7(4):e47 [FREE Full text] [doi: 10.2196/jmir.7.4.e47] [Medline: 16236699]
30. White CB, Moyer CA, Stern DT, Katz SJ. A content analysis of e-mail communication between patients and their providers:
patients get the message. J Am Med Inform Assoc 2004;11(4):260-267 [FREE Full text] [doi: 10.1197/jamia.M1445]
[Medline: 15064295]
31. Smith SG, O'Conor R, Aitken W, Curtis LM, Wolf MS, Goel MS. Disparities in registration and use of an online patient
portal among older adults: findings from the LitCog cohort. J Am Med Inform Assoc 2015 Jul;22(4):888-895 [FREE Full
text] [doi: 10.1093/jamia/ocv025] [Medline: 25914099]
32. Roblin DW, Houston TK, Allison JJ, Joski PJ, Becker ER. Disparities in use of a personal health record in a managed care
organization. J Am Med Inform Assoc 2009;16(5):683-689 [FREE Full text] [doi: 10.1197/jamia.M3169] [Medline:
19567790]
33. Ralston J, Rutter CM, Carrell D, Hecht J, Rubanowice D, Simon GE. Patient use of secure electronic messaging within a
shared medical record: a cross-sectional study. J Gen Intern Med 2009 Mar;24(3):349-355 [FREE Full text] [doi:
10.1007/s11606-008-0899-z] [Medline: 19137379]
34. Connell AM. Employing complier average causal effect analytic methods to examine effects of randomized encouragement
trials. Am J Drug Alcohol Abuse 2009;35(4):253-259 [FREE Full text] [doi: 10.1080/00952990903005882] [Medline:
20180678]
35. Schmittdiel J, Uratsu CS, Karter AJ, Heisler M, Subramanian U, Mangione CM, et al. Why don't diabetes patients achieve
recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med 2008
May;23(5):588-594 [FREE Full text] [doi: 10.1007/s11606-008-0554-8] [Medline: 18317847]
Abbreviations
BP: blood pressure
HbA1c: hemoglobin A1c
ICD-9-CM: International Classification of Diseases, Ninth Revision, Clinical Modification
LDL: low density lipoprotein
MHV: My HealtheVet
PHR: personal health record
SM: secure messaging
VA: Department of Veterans Affairs
Edited by G Eysenbach; submitted 22.02.16; peer-reviewed by K Blondon, J Whealin; comments to author 17.03.16; revised version
received 03.05.16; accepted 19.05.16; published 01.07.16
Please cite as:
Shimada SL, Allison JJ, Rosen AK, Feng H, Houston TK
Sustained Use of Patient Portal Features and Improvements in Diabetes Physiological Measures
J Med Internet Res 2016;18(7):e179
URL: http://www.jmir.org/2016/7/e179/ 
doi:10.2196/jmir.5663
PMID:27369696
©Stephanie L Shimada, Jeroan J Allison, Amy K Rosen, Hua Feng, Thomas K Houston. Originally published in the Journal of
Medical Internet Research (http://www.jmir.org), 01.07.2016. This is an open-access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0/), which permits unrestricted use, distribution,
J Med Internet Res 2016 | vol. 18 | iss. 7 | e179 | p.12http://www.jmir.org/2016/7/e179/
(page number not for citation purposes)
Shimada et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is
properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this
copyright and license information must be included.
J Med Internet Res 2016 | vol. 18 | iss. 7 | e179 | p.13http://www.jmir.org/2016/7/e179/
(page number not for citation purposes)
Shimada et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
